In a filing, Mersana Therapeutics Inc revealed its SVP, COO & CFO DeSchuytner Brian unloaded Company’s shares for reported $16178.0 on Oct 02 ’24. In the deal valued at $2.00 per share,8,089 shares were sold. As a result of this transaction, DeSchuytner Brian now holds 100,422 shares worth roughly $0.2 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, DeSchuytner Brian sold 5,598 shares, generating $10,972 in total proceeds. Upon selling the shares at $1.96, the SVP, COO & CFO now owns 94,824 shares.
Before that, Carvajal Alejandra sold 8,089 shares. Mersana Therapeutics Inc shares valued at $16,178 were divested by the SVP, Chief Legal Officer at a price of $2.00 per share. As a result of the transaction, Carvajal Alejandra now holds 69,314 shares, worth roughly $0.14 million.
JP Morgan upgraded its Mersana Therapeutics Inc [MRSN] rating to a Neutral from a an Underweight in a research note published recently. A number of analysts have revised their coverage, including Wedbush’s analysts, who increased its forecast for the stock in late February from “a Neutral” to “an Outperform”. Guggenheim also remained covering MRSN and has increased its forecast on February 29, 2024 with a “Buy” recommendation from previously “Neutral” rating. BTIG Research revised its rating on February 29, 2024. It rated MRSN as “a Buy” which previously was an “a Neutral”.
Price Performance Review of MRSN
On Monday, Mersana Therapeutics Inc [NASDAQ:MRSN] saw its stock fall -7.55% to $1.96. Over the last five days, the stock has gained 3.70%. Mersana Therapeutics Inc shares have fallen nearly -15.52% since the year began. Nevertheless, the stocks have risen 41.01% over the past one year. While a 52-week high of $6.28 was reached on 03/11/24, a 52-week low of $1.07 was recorded on 08/14/24. SMA at 50 days reached $1.69, while 200 days put it at $2.81.
Levels Of Support And Resistance For MRSN Stock
The 24-hour chart illustrates a support level at 1.90, which if violated will result in even more drops to 1.83. On the upside, there is a resistance level at 2.07. A further resistance level may holdings at 2.18. The Relative Strength Index (RSI) on the 14-day chart is 54.03, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 63.00%. Stochastics %K at 51.67% indicates the stock is a holding.
How much short interest is there in Mersana Therapeutics Inc?
A steep rise in short interest was recorded in Mersana Therapeutics Inc stocks on 2024-09-13, growing by 1.82 million shares to a total of 10.31 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 8.49 million shares. There was a rise of 17.65%, which implies that there is a positive sentiment for the stock.
